Products
Platform
Research
Market
Learn
IPO
Compare Nippon India Pharma Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.8 | 1.93 |
NAV | ₹515.02 | ₹433.66 |
Fund Started | 10 May 2004 | 04 Jun 1999 |
Fund Size | ₹8346.49 Cr | ₹4082.13 Cr |
Exit Load | Exit load of 1% if redeemed within 1 month. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.8
1.93
NAV
₹515.02
₹433.66
Fund Started
10 May 2004
04 Jun 1999
Fund Size
₹8346.49 Cr
₹4082.13 Cr
Exit Load
Exit load of 1% if redeemed within 1 month.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | 1.75% | 3.38% |
3 Year | 21.43% | 24.80% |
5 Year | 17.86% | 19.54% |
1 Year
1.75%
3.38%
3 Year
21.43%
24.80%
5 Year
17.86%
19.54%
Holding Analysis
Equity | 99.44% | 96.05% |
Cash | 0.56% | 3.88% |
Equity
99.44%
96.05%
Cash
0.56%
3.88%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.29% |
Lupin Ltd. | 7.26% |
Divi's Laboratories Ltd. | 7.01% |
Cipla Ltd. | 6.48% |
Apollo Hospitals Enterprise Ltd. | 5.92% |
Dr. Reddy's Laboratories Ltd. | 5.91% |
Vijaya Diagnostic Centre Ltd. | 3.56% |
Medplus Health Services Ltd. | 3.39% |
Gland Pharma Ltd. | 3.24% |
Glaxosmithkline Pharmaceuticals Ltd. | 2.99% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.18% |
Divi's Laboratories Ltd. | 7.26% |
Max Healthcare Institute Ltd. | 5.62% |
Cipla Ltd. | 4.41% |
Lonza Group Ag | 4.05% |
Lupin Ltd. | 4.04% |
Acutaas Chemicals Ltd. | 3.81% |
Fortis Healthcare Ltd. | 3.76% |
Torrent Pharmaceuticals Ltd. | 3.49% |
Jupiter Life Line Hospitals Ltd. | 3.46% |
Fund Manager
Name | Akshay Sharma | Tanmaya Desai |
Start Date | 01 Dec 2022 | 17 May 2024 |
Name
Akshay Sharma
Tanmaya Desai
Start Date
01 Dec 2022
17 May 2024
About Fund
Description | The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 10 May 2004 | 04 Jun 1999 |
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
10 May 2004
04 Jun 1999